搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae VPS10 homolog 2 (VTH2), partial CSB-YP340317SVG
CSB-EP340317SVG
CSB-BP340317SVG
CSB-MP340317SVG
CSB-EP340317SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Regulation of enolase protein 1 (REE1) CSB-YP340318SVG
CSB-EP340318SVG
CSB-BP340318SVG
CSB-MP340318SVG
CSB-EP340318SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YJL211C (YJL211C) CSB-YP340319SVG
CSB-EP340319SVG
CSB-BP340319SVG
CSB-MP340319SVG
CSB-EP340319SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Sexual differentiation process putative amino-acid permease isp5 (isp5), partial CSB-YP340320SXV
CSB-EP340320SXV
CSB-BP340320SXV
CSB-MP340320SXV
CSB-EP340320SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides posadasii Arginase (ARG) CSB-YP340321DUW
CSB-EP340321DUW
CSB-BP340321DUW
CSB-MP340321DUW
CSB-EP340321DUW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Transcriptional activator HAP3 (HAP3) CSB-YP340322KBK
CSB-EP340322KBK
CSB-BP340322KBK
CSB-MP340322KBK
CSB-EP340322KBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Phosphoglycerate kinase (pgk) CSB-YP340323BRJ
CSB-EP340323BRJ
CSB-BP340323BRJ
CSB-MP340323BRJ
CSB-EP340323BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Trifunctional enzyme subunit alpha, mitochondrial (HADHA) CSB-YP340324HU
CSB-BP340324HU
CSB-MP340324HU
CSB-EP340324HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized HTH-type transcriptional regulator yuxN (yuxN) CSB-YP340325BRJ
CSB-EP340325BRJ
CSB-BP340325BRJ
CSB-MP340325BRJ
CSB-EP340325BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Chitinase 2 (CHT2), partial CSB-YP340326CZD
CSB-EP340326CZD
CSB-BP340326CZD
CSB-MP340326CZD
CSB-EP340326CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitotic spindle checkpoint component MAD2 (MAD2) CSB-YP340327SVG
CSB-EP340327SVG
CSB-BP340327SVG
CSB-MP340327SVG
CSB-EP340327SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Histone acetyltransferase SAS2 (SAS2) CSB-YP340328SVG
CSB-EP340328SVG
CSB-BP340328SVG
CSB-MP340328SVG
CSB-EP340328SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Centromere DNA-binding protein complex CBF3 subunit B (CEP3), partial CSB-YP340329SVG
CSB-EP340329SVG
CSB-BP340329SVG
CSB-MP340329SVG
CSB-EP340329SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lilium longiflorum Pectate lyase CSB-YP340330LFR
CSB-EP340330LFR
CSB-BP340330LFR
CSB-MP340330LFR
CSB-EP340330LFR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase 1 (plc1), partial CSB-YP340331SXV
CSB-EP340331SXV
CSB-BP340331SXV
CSB-MP340331SXV
CSB-EP340331SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Probable E3 ubiquitin-protein ligase HUL4 (HUL4), partial CSB-YP340332SVG
CSB-EP340332SVG
CSB-BP340332SVG
CSB-MP340332SVG
CSB-EP340332SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae 1,3-beta-glucan synthase component GSC2 (GSC2), partial CSB-YP340333SVG
CSB-EP340333SVG
CSB-BP340333SVG
CSB-MP340333SVG
CSB-EP340333SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae RNA polymerase I-specific transcription initiation factor RRN7 (RRN7), partial CSB-YP340334SVG
CSB-EP340334SVG
CSB-BP340334SVG
CSB-MP340334SVG
CSB-EP340334SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein scd2/ral3 (scd2), partial CSB-YP340335SXV
CSB-EP340335SXV
CSB-BP340335SXV
CSB-MP340335SXV
CSB-EP340335SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum DNA topoisomerase 2 (TOP2), partial CSB-YP340336EWT
CSB-EP340336EWT
CSB-BP340336EWT
CSB-MP340336EWT
CSB-EP340336EWT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>